ArticleTranslational oncology2019

Oncologic Outcomes in Metastatic Colorectal Cancer with Regorafenib with FOLFIRI as a Third- or Fourth-Line Setting.

Cheng-Jen Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.